|
Volumn 84, Issue 5, 2005, Pages 422-427
|
Cost of heart failure in the unified health system;Custo da insuficiência cardíaca no sistema único de saúde
|
Author keywords
Cost of disease; Health economy; Heart failure
|
Indexed keywords
ACETYLSALICYLIC ACID;
AMINOFILINA;
AMIODARONE;
AMLODIPINE;
ATENOLOL;
ATORVASTATIN;
BUDESONIDE PLUS FORMOTEROL;
CAPTOPRIL;
CARDIAC AGENT;
CARVEDILOL;
CLONIDINE;
CLOPIDOGREL;
DIGITALIS;
DILTIAZEM;
DINITRATO;
ENALAPRIL;
FENOTEROL PLUS IPRATROPIUM BROMIDE;
FUROSEMIDE;
GEMFIBROZIL;
GLIBENCLAMIDE;
GLIMEPIRIDE;
HYDRALAZINE;
HYDROCHLOROTHIAZIDE;
INSULIN;
LOSARTAN;
METFORMIN;
METOPROLOL;
MONONITRATO;
NIFEDIPINE;
OMEPRAZOLE;
PRAVASTATIN;
PREDNISONE;
PROPATILNITRATO;
PROPRANOLOL;
RANITIDINE;
SIMVASTATIN;
SPIRONOLACTONE;
TIAMINA;
TICLOPIDINE;
UNCLASSIFIED DRUG;
VALSARTAN;
VERAPAMIL;
WARFARIN;
ADULT;
AMBULATORY CARE;
ARTICLE;
CONTROLLED STUDY;
DRUG COST;
ECONOMIC EVALUATION;
FEMALE;
HEALTH CARE COST;
HEART FAILURE;
HOSPITAL BILLING;
HOSPITAL CHARGE;
HOSPITAL COST;
HOSPITALIZATION;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
RETIREMENT;
|
EID: 18944366267
PISSN: 0066782X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (44)
|
References (13)
|